Clinical studies on pramipexol retard;A pramipexol retard klinikai vizsgálatai

Ideggyogyaszati Szemle

Volumn 63, Issue 5-6, 2010, Pages 171-174

  Klivényi, Péter ^a   Vécsei, László ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Parkinson's disease; Pramipexol; Prolonged release

Indexed keywords

PRAMIPEXOLE; ANTIPARKINSON AGENT; BENZOTHIAZOLE DERIVATIVE; PRAMIPEXOL;

ARTICLE; CLINICAL TRIAL (TOPIC); DELAYED DRUG RELEASE; DOPAMINERGIC NERVE CELL; HUMAN; NERVE STIMULATION; PARKINSON DISEASE; PATIENT COMPLIANCE; AGED; DELAYED RELEASE FORMULATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; FEMALE; MALE; MIDDLE AGED; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; REVIEW; TREATMENT OUTCOME;

AGED; ANTIPARKINSON AGENTS; BENZOTHIAZOLES; CLINICAL TRIALS, PHASE III AS TOPIC; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PARKINSON DISEASE; TREATMENT OUTCOME;

EID: 77955972212     PISSN: 00191442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Jenner P, Könen-Bergmann M, Schepers C, Haertter S. Pharmacokinetics of a Once-Daily extended-release formulation of pramipexole in healthy male volunteers: Three studies. Clin Ther 2009;31:2698-711.
2. Hauser R, Salin L, Koester J. Double-blind evaluation of pramipexole extended-release (ER) in early Parkinson's disease. American Academy of Neurology 61st Annual Meeting Platform S43.003, Seattle, USA 2009.
3. Rascol O, Barone P, Hauser R, Mizuno Y, Poewe W, Schapira A, et al. Easy Switching from immediate to extended-release pramipexole in early Parkinson's disease at the same daily dosage. Movment Dis 2009;24(Suppl 1):Th-255.
4. Schapira A, Barone P, Hauser R, Mizuno Y, Poewe W, Rascol O, et al. Efficacy and safety of pramipexole extended-release for advanced Parkinson's disease. Movment Dis 2009;24(Suppl 1):We-199.